Femseven Sequi is a type of hormone replacement therapy (HRT) designed primarily for women going through menopause. It is formulated to alleviate symptoms associated with menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness. Femseven Sequi works by providing the body with estrogen and progestogen, hormones that are produced in lower quantities during menopause. This medication is typically administered through a transdermal patch, which allows for the hormones to be absorbed directly into the bloodstream through the skin. The "Sequi" in its name indicates a sequential regimen, meaning that the treatment is divided into two phases with different hormone combinations to more closely mimic the natural menstrual cycle. This approach is often used for women who have not had a hysterectomy and still have their uterus, as it helps to manage the endometrial lining and reduce the risk of endometrial cancer associated with estrogen-only HRT.